Information Journal Paper
APA:
CopyESKANDARI NASAB, E., HASHEMI, M., & EBRAHIMI, M.. (2014). EVALUATION OF CCL5 -403 G>A AND CCR5 DELTA32 GENE POLYMORPHISMS IN PATIENTS WITH BREAST CANCER. CANCER BIOMARKERS : SECTION A OF DISEASE MARKERS, 14(-), 343-351. SID. https://sid.ir/paper/682636/en
Vancouver:
CopyESKANDARI NASAB E., HASHEMI M., EBRAHIMI M.. EVALUATION OF CCL5 -403 G>A AND CCR5 DELTA32 GENE POLYMORPHISMS IN PATIENTS WITH BREAST CANCER. CANCER BIOMARKERS : SECTION A OF DISEASE MARKERS[Internet]. 2014;14(-):343-351. Available from: https://sid.ir/paper/682636/en
IEEE:
CopyE. ESKANDARI NASAB, M. HASHEMI, and M. EBRAHIMI, “EVALUATION OF CCL5 -403 G>A AND CCR5 DELTA32 GENE POLYMORPHISMS IN PATIENTS WITH BREAST CANCER,” CANCER BIOMARKERS : SECTION A OF DISEASE MARKERS, vol. 14, no. -, pp. 343–351, 2014, [Online]. Available: https://sid.ir/paper/682636/en